Respiro supports respiratory remote patient monitoring (RPM) by turning everyday inhaler use into objective adherence, inhalation-technique and risk signals for clinicians, care teams and respiratory services. Patients keep using their inhalers; your team sees who is controlled, who is drifting, and what to review before the next consultation.
The provider value is not just more data. It is a clearer split of work across the people involved in care: clinicians get better visits, care teams get a prioritised panel, and respiratory services get a monitoring model that grows beyond one clinic.
See real adherence and inhalation technique before the consultation, so the visit can focus on the patient's pattern, barriers and treatment plan rather than recollection.
Rising rescue use, missed controller doses or slipping technique can move a patient up the review queue, helping staff focus attention where it is most likely to matter.
Clinic-ready summaries, panel views and integration pathways let respiratory services move from individual device data to a repeatable monitoring programme.
Rising rescue-inhaler use and technique changes create an earlier care signal, prompting review on Wednesday, not only at the next scheduled appointment.
The strongest provider programmes make the workflow explicit: enrol the right patients, capture data automatically, prioritise the panel, then review or reach out with a concise summary. Respiro is built to support that operating model without asking the clinic to run a separate device programme.
Start with the respiratory cohort where visibility would change management: uncontrolled asthma, COPD, high reliever use, recent exacerbations or therapy escalation.
Embedded or add-on sensing records dose timing and inhalation quality as patients use their inhalers, reducing manual logs and recall bias.
Panel views help staff sort by adherence gaps, reliever spikes, technique changes and unresolved reviews, so outreach starts with the patients most likely to need it.
Clinic-ready summaries support pre-visit review, remote check-ins and documentation into the record or partner workflow where the deployment supports it.
Respiro evidence suggests that making adherence and inhalation technique visible can improve asthma control and reduce the downstream burden of poorly-controlled disease. The numbers belong to specific study populations, not a blanket promise for every clinic.
Figures come from individual Respiro studies (a cluster RCT (n=68, ERS 2022), a real-world service evaluation (n=59, RDD 2026) and earlier pilots) and describe study populations, not a promise of individual results. Conference results are labelled as such. See the evidence →
Successful connected-respiratory programmes define the clinical question first: who should be enrolled, which signals trigger review, who owns outreach, and where the summary is documented.
Respiro is designed to support that programme design across a single clinic, a respiratory service or a broader provider network, including integration and reimbursement pathways where they apply.
Respiro combines objective, device-linked adherence and inhalation-quality data with a regulated platform foundation: the kind of signal claims data, refill history and self-report cannot provide on their own.
Respiro runs on secure cloud infrastructure under an ISO 13485:2016 quality system, with GDPR- and HIPAA-aligned deployments, so the patient data you rely on is handled to medical-device standards, not bolted-on afterthoughts.
See quality & complianceLet's map the cohort, workflow, review rules and evidence goals that would make Respiro useful in your clinic or respiratory service.